Harbinder Singh

Dr. Harbinder Singh

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2018 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
HSHarbinder Singh
Harbinder Singh
JSJatinder Vir Singh
Jatinder Vir Singh
NKNavdeep Kaur
Navdeep Kaur
MSMohit Sanduja
Mohit Sanduja
GSGurpreet Singh
Gurpreet Singh
Sahil SharmaSahil Sharma
Sahil Sharma
Background: Esterase is an enzyme that splits esters into an acid and alcohol. Varieties of esterases are present in human body to control diverse set of cellular processes and execute their specific functions. It can be seen that any increase in metabolites produced by these enzymes lead to severe pathological conditions like Alzheimer disease, hypercholesterolemia etc. Objective: Numerous esterase inhibitors have been developed and reported by the researchers around the globe, but not systematically summarized yet. Therefore, this assemblage focuses on various reported esterase inhibitors during recent past with detailed account of the design strategies employed for the synthesis of novel drug entities. The article also highlights the structure activity relationship along with mechanistic insights revealed during the biological evaluation of inhibitors as esterase inhibition. The interactions with the amino acid residues responsible for esterase inhibitory potential of molecules have also been discussed. This compilation will be of great interest for the researchers working in the area of esterase inhibitors. Conclusion: Rivastigmine derivatives (44-53), tacrine-piperazine hybrid (136), coumarin-benzofuran derivative (169), coumarin-benzylpiperidine hybrid (181) and phenylcinnamide derivative (220) found to be exerting cholinesterase inhibition with IC50 below the range of 1 nM. Whereas, flavone (258) has displayed anticholesterol esterase potential below 1 nM. Benzil like derivative, (273) has also been designed and reported to possess remarkable inhibitory potential (IC50 < 1 nM) against carboxylesterase. These representative results place them in forefront as potential future drug candidates to further develop potent and specific esterase inhibitors.

1 August 2019 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
HSHarbinder Singh
Harbinder Singh
JSJatinder Vir Singh
Jatinder Vir Singh
KBKavita Bhagat
Kavita Bhagat
HGHarmandeep Kaur Gulati
Harmandeep Kaur Gulati
MSMohit Sanduja
Mohit Sanduja
Sahil SharmaSahil Sharma
Sahil Sharma

1 September 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
HSHarbinder Singh
Harbinder Singh
JSJatinder V. Singh
Jatinder V. Singh
MGManish Kumar Gupta
Manish Kumar Gupta
ASAjit K. Saxena
Ajit K. Saxena
Sahil SharmaSahil Sharma
Sahil Sharma
PBPreet Mohinder Singh Bedi
Preet Mohinder Singh Bedi

1 June 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HSHarbinder Singh
Harbinder Singh
MKMandeep Kumar
Mandeep Kumar
KNKunal Nepali
Kunal Nepali
MGManish Kumar Gupta
Manish Kumar Gupta
ASAjit K. Saxena
Ajit K. Saxena
PBPreet Mohinder Singh Bedi
Preet Mohinder Singh Bedi

22 May 2019 in ACS Omega
Verified
Journal Article
Open access
KBKavita Bhagat
Kavita Bhagat
JBJyoti Bhagat
Jyoti Bhagat
MGManish Kumar Gupta
Manish Kumar Gupta
JSJatinder Vir Singh
Jatinder Vir Singh
HGHarmandeep Kaur Gulati
Harmandeep Kaur Gulati
PBPreet Mohinder Singh Bedi
Preet Mohinder Singh Bedi
Keeping in view various pharmacological attributes of indole and coumarin derivatives, a new series of indolindione–coumarin molecular hybrids was rationally designed and synthesized. All synthesized hybrid molecules were evaluated for their antimicrobial potential against Gram-negative bacterial strains (Escherichia coli and Salmonella enterica), Gram-positive bacterial strains (Staphylococcus aureus and Mycobacterium smegmatis), and four fungal strains (Candida albicans, Alternaria mali, Penicillium sp., and Fusarium oxysporum) by using the agar gel diffusion method. Among all synthetics, compounds K-1 and K-2 were found to be the best antimicrobial agents with the minimum inhibitory concentration values of 30 and 312 μg/mL, against Penicillium sp. and S. aureus, respectively. The biological data revealed some interesting facts about the structure–activity relationship which state that the electronic environment on the indolinedione moiety and carbon chain length between indolinedione and triazole moieties considerably affect the antimicrobial potential of the synthesized hybrids. Various types of binding interactions of K-2 within the active site of S. aureus dihydrofolate reductase were also streamlined by molecular modeling studies, which revealed the possible mechanism for potent antibacterial activity of the compound.

5 July 2019 in ACS Omega
Verified
Journal Article
Open access
ASAtamjit Singh
Atamjit Singh
JSJatinder Vir Singh
Jatinder Vir Singh
ARAbhineet Rana
Abhineet Rana
KBKavita Bhagat
Kavita Bhagat
HGHarmandeep Kaur Gulati
Harmandeep Kaur Gulati
PBPreet Mohinder Singh Bedi
Preet Mohinder Singh Bedi
Keeping in view various pharmacological attributes of curcumin, coumarin, and isatin derivatives, triazole-tethered monocarbonyl curcumin–coumarin and curcumin–isatin molecular hybrids have been synthesized and evaluated for their antibacterial potential against Gram-positive (Enterococcus faecalis and Staphylococcus aureus) and Gram-negative (Pseudomonas aeruginosa and Escherichia coli) human pathogenic bacterial strains. Among all hybrid molecules, A-4 and B-38 showed the most potent antibacterial activity with inhibition zones of 29 and 31 mm along with MIC values of 12.50 and 6.25 μg/mL, respectively. Structure–activity relationship that emerged from biological data revealed that the two-carbon alkyl chain between triazole and coumarin/isatin moiety is well tolerable for the activity. Bromo substitution at the fifth position of isatin, para-cholo substitution in the case of curcumin–isatin, and para-methoxy in the case of curcumin–coumarin hybrids on ring A of curcumin are most suitable groups for the antibacterial activity. Various types of binding interactions of A-4 and B-38 within the active site of dihydrofolate reductase (DHFR) of S. aureus are also streamlined by molecular modeling studies, suggesting their capability in completely blocking DHFR.